Pediatrix Medical Group (NYSE:MD) Trading 7.5% Higher

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) traded up 7.5% during mid-day trading on Tuesday . The company traded as high as $9.98 and last traded at $9.98. 41,582 shares changed hands during trading, a decline of 94% from the average session volume of 672,949 shares. The stock had previously closed at $9.28.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on MD shares. Jefferies Financial Group cut their target price on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Mizuho reduced their target price on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. TheStreet lowered shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Finally, Truist Financial decreased their price objective on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research note on Wednesday, February 21st. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $9.38.

Pediatrix Medical Group Trading Down 3.9 %

The firm has a market capitalization of $686.49 million, a P/E ratio of -11.19, a price-to-earnings-growth ratio of 2.52 and a beta of 1.58. The firm has a fifty day simple moving average of $9.21 and a two-hundred day simple moving average of $9.38. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.24 and a quick ratio of 1.24.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, February 20th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.02. The firm had revenue of $496.44 million during the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. The company’s revenue was down 3.4% on a year-over-year basis. During the same quarter last year, the company earned $0.46 earnings per share. On average, equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Pacer Advisors Inc. boosted its stake in Pediatrix Medical Group by 126.9% during the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock valued at $30,092,000 after buying an additional 1,809,828 shares during the period. Smith Graham & Co. Investment Advisors LP raised its stake in Pediatrix Medical Group by 51.5% in the fourth quarter. Smith Graham & Co. Investment Advisors LP now owns 534,621 shares of the company’s stock valued at $4,972,000 after purchasing an additional 181,662 shares in the last quarter. Nordea Investment Management AB lifted its position in Pediatrix Medical Group by 0.6% during the third quarter. Nordea Investment Management AB now owns 219,561 shares of the company’s stock valued at $2,810,000 after purchasing an additional 1,221 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Pediatrix Medical Group by 43.7% in the 3rd quarter. AQR Capital Management LLC now owns 559,879 shares of the company’s stock worth $7,116,000 after buying an additional 170,375 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Pediatrix Medical Group by 4.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,485,465 shares of the company’s stock worth $18,880,000 after acquiring an additional 57,193 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.